Nu Skin Enterprises, Inc. (NUS) revenue by segment
NUSNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 12/3069% below fair value
$3.87+0.09 (+2.38%)
Close on Nov 18, 2026Market cap $188.38MP/E –Yield –
Doanh thu theo bộ phận của Nu Skin Enterprises, Inc.
Theo bộ phận kinh doanh
| Doanh thu | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % doanh thu | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Americas | $282.98M | $322.52M | $398.22M | $508.54M | $547.76M | $453.02M | $304.42M | – | – | – | 19.1% | -12.3% |
| Southeast Asia/Pacific | $209.80M | $244.85M | $267.21M | $344.41M | $336.65M | $361.63M | $346.28M | – | – | – | 14.1% | -14.3% |
| Manufacturing | $205.79M | $201.43M | $181.40M | $149.46M | $172.12M | $149.34M | $121.92M | $90.61M | $0 | – | 13.9% | +2.2% |
| Mainland China | $195.55M | $235.24M | $298.08M | $360.39M | $568.77M | $625.54M | $722.53M | $886.47M | – | – | 13.2% | -16.9% |
| Japan | $174.36M | $181.56M | $207.83M | $224.90M | $266.22M | $273.68M | $260.04M | $254.94M | – | – | 11.7% | -4.0% |
| Europe & Africa | $150.15M | $164.16M | $192.35M | $204.28M | $283.20M | – | – | – | – | – | 10.1% | -8.5% |
| South Korea | $130.22M | $163.71M | $236.10M | $268.71M | $354.25M | $326.48M | $329.98M | $373.36M | – | – | 8.8% | -20.5% |
| Hong Kong/Taiwan | $117.38M | $130.61M | $153.59M | $157.20M | $162.61M | $161.12M | $166.34M | $185.89M | – | – | 7.9% | -10.1% |
| Rhyz Other | $17.79M | $85.19M | $35.21M | $3.83M | $437.00K | $0 | $0 | – | – | – | 1.2% | -79.1% |
| Rhyz | – | – | $216.61M | $153.29M | $172.56M | – | – | – | – | – | – | – |
| Nu Skin | – | – | $1.75B | $2.07B | $2.52B | $2.43B | $2.30B | $2.59B | – | – | – | – |
| Other | – | – | -$858.00K | $3.96M | $3.65M | $886.00K | $1.62M | $3.42M | $6.30M | – | – | – |
| Rhyz Investments | – | – | – | $153.29M | $172.56M | $149.34M | $122.05M | – | – | – | – | – |
| EMEA | – | – | – | $204.28M | $283.20M | $230.25M | $167.17M | $182.39M | – | – | – | – |
| Grow Tech | – | – | – | – | $2.10M | $903.00K | $137.00K | $0 | $0 | – | – | – |
| Americas/Pacific | – | – | – | – | – | $511.94M | $349.08M | $385.03M | – | – | – | – |
| Southeast Asia | – | – | – | – | – | $302.71M | $301.62M | $316.89M | – | – | – | – |
| Lợi nhuận hoạt động | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Americas | $60.49M | $67.72M | $78.94M | $97.30M | $103.07M | $86.39M | $52.14M | – | – | – | -10.7% |
| Japan | $48.97M | $50.80M | $54.08M | $51.62M | $65.17M | $68.03M | $61.08M | $56.68M | – | – | -3.6% |
| Southeast Asia/Pacific | $46.78M | $45.23M | $47.74M | $75.90M | $72.77M | $87.75M | $90.67M | – | – | – | +3.4% |
| Mainland China | $45.56M | $46.09M | $62.26M | $72.36M | $151.65M | $181.02M | $191.57M | $253.60M | – | – | -1.2% |
| South Korea | $37.46M | $50.75M | $74.09M | $78.81M | $110.33M | $100.93M | $99.89M | $107.22M | – | – | -26.2% |
| Hong Kong/Taiwan | $37.17M | $34.69M | $40.58M | $32.58M | $34.07M | $33.47M | $33.57M | $33.39M | – | – | +7.2% |
| Europe & Africa | $22.63M | $21.01M | $18.59M | $15.96M | $34.85M | – | – | – | – | – | +7.7% |
| Manufacturing | $7.81M | $1.46M | $12.32M | $3.57M | $18.35M | $21.17M | $15.69M | $7.75M | $0 | – | +435.1% |
| Rhyz Other | -$30.59M | -$45.81M | -$20.56M | -$6.18M | -$1.81M | $0 | $0 | – | – | – | -33.2% |
| Rhyz | – | – | -$8.24M | -$2.61M | $16.53M | – | – | – | – | – | – |
| Nu Skin | – | – | $376.29M | $424.54M | $571.89M | $581.67M | $539.11M | $596.69M | – | – | – |
| Rhyz Investments | – | – | – | -$2.61M | $16.53M | $21.17M | -$3.82M | – | – | – | – |
| EMEA | – | – | – | $21.45M | $41.99M | $24.08M | $10.20M | $14.77M | – | – | – |
| Grow Tech | – | – | – | – | -$83.91M | -$22.43M | -$19.51M | -$9.23M | $0 | – | – |
| Americas/Pacific | – | – | – | – | – | $91.63M | $57.09M | $52.43M | – | – | – |
| Southeast Asia | – | – | – | – | – | $75.54M | $82.46M | $78.60M | – | – | – |
Theo sản phẩm hoặc dịch vụ
| Doanh thu | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % doanh thu | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wellness | $689.06M | $757.22M | $886.09M | $992.34M | $1.06B | $922.55M | $863.13M | $921.33M | $817.23M | – | 46.4% | -9.0% |
| Beauty | $568.11M | $681.77M | $858.63M | $1.07B | $1.44B | $1.49B | $1.42B | – | – | – | 38.3% | -16.7% |
| Other | $227.98M | $293.10M | $224.41M | $163.61M | $190.46M | $167.58M | $133.81M | $97.94M | $5.48M | $6.92M | 15.4% | -22.2% |
| Devices and Related Consumables | – | – | – | – | $658.00M | $712.00M | $618.00M | – | – | – | – | – |
| Personal Care | – | – | – | – | – | $1.49B | $1.42B | $1.66B | $1.46B | – | – | – |
| Pharmanex | – | – | – | – | – | – | – | $921.33M | $817.23M | $892.74M | – | – |
| Nu Skin | – | – | – | – | – | – | – | $1.66B | $1.46B | $1.31B | – | – |
Theo khu vực
| Doanh thu | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % doanh thu | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Japan | – | – | – | – | – | – | – | $254.94M | $256.09M | $279.04M | – | – |
| South Korea | – | – | – | – | – | – | – | $373.36M | $361.69M | $413.70M | – | – |
| China | – | – | – | – | – | – | – | $886.47M | $716.99M | $610.41M | – | – |
| EMEA | – | – | – | – | – | – | – | $182.39M | $160.28M | $147.32M | – | – |
| Hong Kong/Taiwan | – | – | – | – | – | – | – | $185.89M | $166.70M | $183.98M | – | – |
| Americas/Pacific | – | – | – | – | – | – | – | $385.03M | $342.43M | $298.77M | – | – |
| Southeast Asia | – | – | – | – | – | – | – | $316.89M | $268.63M | $271.90M | – | – |
| Other | – | – | – | – | – | – | – | $94.03M | $6.30M | $2.68M | – | – |
| Americas | – | – | – | – | – | – | – | – | $317.38M | $276.59M | – | – |
| South Asia/Pacific | – | – | – | – | – | – | – | – | $299.98M | $296.76M | – | – |
| United States | – | – | – | – | – | – | – | – | $218.73M | $201.24M | – | – |
| All Others | – | – | – | – | – | – | – | – | $725.60M | $703.41M | – | – |
Lấy từ thuyết minh bộ phận và phân tách doanh thu trong hồ sơ 10-K, 10-Q của Nu Skin Enterprises (XBRL). Số quý 4 bằng cả năm tài chính trừ chín tháng đầu. Tên bộ phận giữ theo cách công ty tự đặt và có thể đổi khi công ty tái cấu trúc. Tab KPI hiện các bộ phận này cạnh chỉ số vận hành của Nu Skin Enterprises, kèm đầy đủ lịch sử, biểu đồ và liên kết tới từng hồ sơ.
See a number that looks wrong?